The University of Alberta has announced a new laboratory and endowed chair to research the connection between microbiota and mood disorders and immune conditions such as depression and asthma. The research is supported by a gift from pharmaceutical company AstraZeneca. The AstraZeneca Canada Inc Chair in Asthma and Obstructive Lung Disease will be held by UAlberta Associate Professor Paul Forsythe, who will set up a lab and research team to carry out the study. “Today’s endowment of a chair in asthma and obstructive lung disease is one more example of how we are working towards finding ground-breaking solutions to the benefit of all,” said UAlberta president Bill Flanagan. UAlberta Note: Archived stories may contain dead links or be missing source links.